Kiyotoshi MoriHead of Research Division at Chiome Bioscience Inc.Speaker
Profile
Kiyotoshi Mori is Head of Research Division at Chiome Bioscience Inc., effective April 2026. He brings nearly 30 years of pharmaceutical R&D experience, spanning drug discovery, translational and nonclinical research, portfolio management, external alliances, and research leadership. Before joining Chiome, he held senior roles at Kyowa Kirin, leading research across antibody biologics, ADCs, bispecific antibodies, small molecules, and emerging modalities such as gene and cell therapies, while also promoting academic collaborations with institutions including La Jolla Institute for Immunology. His expertise covers immunology and oncology, particularly hematological malignancies and cancer immunology, as well as autoimmune and allergic diseases.
Agenda Sessions
Advancing Next-Generation Antibody Drug Discovery through Chiome’s DoppeLib Platform and Integrated Drug Discovery Partnerships
, 14:45View Session
